I'd like to ask the same question to Monsieur Beaudet. The governing council is talking about direction and strategy. We have one support letter for this appointment and a number of others against. Doesn't a whole career in the pharmaceutical industry bring a pharmaceutical bias to what should be a neutral approach?
On November 30th, 2009. See this statement in context.